Heron Therapeutics Inc (HRTX)
2.77
-0.17
(-5.78%)
USD |
NASDAQ |
May 10, 16:00
2.77
0.00 (0.00%)
After-Hours: 18:27
Heron Therapeutics Gross Profit (Quarterly): 24.35M for Dec. 31, 2023
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 24.35M |
September 30, 2023 | 13.23M |
June 30, 2023 | 11.60M |
March 31, 2023 | 12.76M |
December 31, 2022 | 17.40M |
September 30, 2022 | 11.84M |
June 30, 2022 | 11.46M |
March 31, 2022 | 12.10M |
December 31, 2021 | 9.714M |
September 30, 2021 | 11.88M |
June 30, 2021 | 7.921M |
March 31, 2021 | 10.81M |
December 31, 2020 | 11.21M |
September 30, 2020 | 12.80M |
June 30, 2020 | 13.66M |
March 31, 2020 | 14.78M |
December 31, 2019 | 19.21M |
September 30, 2019 | 25.43M |
June 30, 2019 | 23.07M |
March 31, 2019 | 16.64M |
December 31, 2018 | 17.27M |
September 30, 2018 | 12.21M |
June 30, 2018 | 12.05M |
March 31, 2018 | 8.434M |
December 31, 2017 | 8.715M |
Date | Value |
---|---|
September 30, 2017 | 7.521M |
June 30, 2017 | 7.497M |
March 31, 2017 | 2.446M |
December 31, 2016 | 1.244M |
September 30, 2016 | 0.00 |
June 30, 2016 | 0.00 |
March 31, 2016 | 0.00 |
December 31, 2015 | |
September 30, 2015 | |
June 30, 2015 | |
March 31, 2015 | |
December 31, 2014 | |
September 30, 2014 | |
June 30, 2014 | |
March 31, 2014 | |
December 31, 2013 | |
September 30, 2013 | |
June 30, 2013 | |
March 31, 2013 | |
December 31, 2012 | |
September 30, 2012 | |
June 30, 2012 | |
March 31, 2012 | |
December 31, 2011 | |
September 30, 2011 | 0.00 |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
7.921M
Minimum
Jun 2021
25.43M
Maximum
Sep 2019
14.49M
Average
12.76M
Median
Mar 2023
Gross Profit (Quarterly) Benchmarks
United Therapeutics Corp | 604.80M |
Esperion Therapeutics Inc | 20.80M |
Aldeyra Therapeutics Inc | -- |
Ocular Therapeutix Inc | 13.42M |
Alpine Immune Sciences Inc | -- |